News

Revenues decreased by $0.4m, compared to the same period in 2010, primarily due to the timing of purchases by the company’s distribution partners. Research and development (R&D) expenses

The aim of the double-blind, randomized and four-period study was to assess the bronchodilatory effect, pharmacokinetics, safety and tolerability of single inhaled doses of TD-4208 in patients with

The WMS is believed to help CSPC standardize and integrate the warehousing and distribution operations resulting in better efficiency and reduced operating costs. The pharmaceutical company can also

The construction of the new 72,000 ft² facility is slated to finish in 2014. It will allow Boehringer to handle production of active pharmaceutical ingredients used in early

The company’s multi-stage drug delivery technology is based on micron-sized particles of porous silicon particles which protect their payload from several key defenses used by the body and

CTP-499 is an analog of 1-((S)-5-hydroxyhexyl)-3,7-dimethylxanthine (HDX), an active metabolite of pentoxifylline and has a pleiotropic mechanism of action including angiotensin converting enzyme inhibitors (ACEi) and angiotensin receptor

Bend has provided Merck with the rights to have access to its proprietary spray-dried dispersion (SDD) technology, as per the agreement. Bend will also provide Merck with access

Proteoderm has used non-embryonic stem cells to develop a matrix of proteins (Matrix NC-138) used to harness the anti-aging potential in cosmeceutical products. Proteonomix president Michael Cohen said

The randomized trial was designed to assess whether the investigational alemtuzumab could achieve efficacy and safety improvements over the approved interferon beta-1a (Rebif). The trial enrolled patients who